Role of Leukotriene Receptor Antagonists in Treatment of Chronic Periodontitis
Status:
Completed
Trial end date:
2013-10-01
Target enrollment:
Participant gender:
Summary
The adjunctive use of Leukotriene Receptor Antagonist (Montelukast) along with scaling and
root planing in patients with chronic periodontitis leads to host inflammatory response
modulation and decrease in serum C reactive protein (CRP) levels. If proven this will open
new vistas in treatment of chronic periodontitis.